-
1مراجعة
المؤلفون: Kavakli, Kaan, Peyvandi, Flora, El-Beshlawy, Amal, Rangarajan, Savita
مصطلحات موضوعية: factor replacement therapy, bypassing agents, haemophilia A, immune tolerance induction, inhibitors, non-factor replacement agents, Recombinant Factor Viia, Activated Factor-Vii, Factor-Ix, Emicizumab Prophylaxis, Bispecific Antibody, Fviii Inhibitors, Randomized-Trial, Gene-Therapy
العلاقة: Haemophilia; Diğer; https://hdl.handle.net/11454/77530Test; https://doi.org/10.1111/hae.14638Test; Peyvandi, Flora/0000-0001-7423-9864; 28; 950; 961
-
2مراجعة
المؤلفون: Peyvandi, Flora, Kavakli, Kaan, El-Beshlawy, Amal, Rangarajan, Savita
مصطلحات موضوعية: bypassing agents, factor replacement therapy, haemophilia A, immune tolerance induction, inhibitors, non-factor replacement agents, Recombinant Factor Viia, Activated Factor-Vii, Factor-Ix, Emicizumab Prophylaxis, Bispecific Antibody, Fviii Inhibitors, Randomized-Trial, Gene-Therapy
العلاقة: Haemophilia; Diğer; https://doi.org/10.1111/hae.14638Test; https://hdl.handle.net/11454/85839Test; 28; 950; 961; WOS:000828817500001; 2-s2.0-85134575573
-
3مراجعة
المؤلفون: Peyvandi, Flora, Kavakli, Kaan, El-Beshlawy, Amal, Rangarajan, Savita
مصطلحات موضوعية: bypassing agents, factor replacement therapy, haemophilia A, immune tolerance induction, inhibitors, non-factor replacement agents, Recombinant Factor Viia, Activated Factor-Vii, Factor-Ix, Emicizumab Prophylaxis, Bispecific Antibody, Fviii Inhibitors, Randomized-Trial, Gene-Therapy
العلاقة: Haemophilia; Diğer; https://doi.org/10.1111/hae.14638Test; https://hdl.handle.net/11454/77530Test; 28; 950; 961; WOS:000828817500001; 2-s2.0-85134575573
-
4مراجعة
المؤلفون: Auerswald, Guenter, Peyvandi, Flora, Austin, Steven K., Liesner, Ri, Kavakli, Kaan, Roman, Maria Teresa Alvarez, Millar, Carolyn M.
مصطلحات موضوعية: Factor X deficiency, Diagnosis, Plasma-derived factor X concentrate, Prothrombin complex concentrates, Rare bleeding disorders, Treatment, Fresh-Frozen Plasma, Prothrombin Complex Concentrate, Light-Chain Amyloidosis, Coagulation Disorders, Replacement Therapy, Hemophilia, Efficacy, Pharmacokinetics, Manifestations
العلاقة: Blood Reviews; Diğer; https://hdl.handle.net/11454/76439Test; https://doi.org/10.1016/j.blre.2021.100833Test; 50
-
5مراجعة
المؤلفون: Peyvandi, Flora, Auerswald, Guenter, Austin, Steven K., Liesner, Ri, Kavakli, Kaan, Roman, Maria Teresa Alvarez, Millar, Carolyn M.
مصطلحات موضوعية: Diagnosis, Factor X deficiency, Plasma-derived factor X concentrate, Prothrombin complex concentrates, Rare bleeding disorders, Treatment, Fresh-Frozen Plasma, Prothrombin Complex Concentrate, Light-Chain Amyloidosis, Coagulation Disorders, Replacement Therapy, Hemophilia, Efficacy, Pharmacokinetics, Manifestations
العلاقة: Blood Reviews; Diğer; https://doi.org/10.1016/j.blre.2021.100833Test; https://hdl.handle.net/11454/76439Test; 50; WOS:000711028300001; 2-s2.0-85106392109
-
6مراجعة
المؤلفون: Peyvandi, Flora, Kavakli, Kaan, El-Beshlawy, Amal, Rangarajan, Savita
مصطلحات موضوعية: bypassing agents, factor replacement therapy, haemophilia A, immune tolerance induction, inhibitors, non-factor replacement agents, Recombinant Factor Viia, Activated Factor-Vii, Factor-Ix, Emicizumab Prophylaxis, Bispecific Antibody, Fviii Inhibitors, Randomized-Trial, Gene-Therapy, psy
-
7مراجعة
المؤلفون: Peyvandi, Flora, Auerswald, Guenter, Austin, Steven K., Liesner, Ri, Kavakli, Kaan, Roman, Maria Teresa Alvarez, Millar, Carolyn M.
مصطلحات موضوعية: Diagnosis, Factor X deficiency, Plasma-derived factor X concentrate, Prothrombin complex concentrates, Rare bleeding disorders, Treatment, Fresh-Frozen Plasma, Prothrombin Complex Concentrate, Light-Chain Amyloidosis, Coagulation Disorders, Replacement Therapy, Hemophilia, Efficacy, Pharmacokinetics, Manifestations, psy, envir